Literature DB >> 20309518

[Pitfalls and difficulties in interpretation of bone densitometry].

R Scholz1, G Borte, G von Salis-Soglio, C-E Heyde.   

Abstract

The clinical relevance of osteoporosis as a frequent systemic skeletal disease is to be found in fractures and their consequences. For prevention of these disease manifestations great importance must be attached to a safest possible diagnosis even before the occurrence of the first fracture and osteodensitometry is a well established technique for this purpose. Among the different measurement procedures DXA (dual-energy X-ray absorptiometry) has become the gold standard worldwide. This method is seen as very reliable and adequately precise. Prerequisites for these characteristics are the correct interpretation of the measurement data obtained by taking into consideration all potential influencing factors which can either false positively or false negatively influence a single value as well as the calculated mean value and the T and Z scores. Thus, exact knowledge of potential sources of error is of crucial importance. The present study shows important sources of error and difficulties in interpretation as well as a discussion of the options for their prevention. For the clinical practice osteodensitometry is to be seen as an important diagnostic component, which can only been interpreted meaningfully with respect to the clinical data.

Entities:  

Mesh:

Year:  2010        PMID: 20309518     DOI: 10.1007/s00132-010-1613-5

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  28 in total

1.  [Possibilities and indications in osteodensitometry].

Authors:  D Felsenberg
Journal:  Z Rheumatol       Date:  2001-04       Impact factor: 1.372

2.  [Osteoporosis].

Authors:  H W Minne; M Pfeifer; B Begerow; W Pollähne
Journal:  Orthopade       Date:  2002-07       Impact factor: 1.087

Review 3.  Bone densitometry. Interpretation and pitfalls.

Authors:  Monica Agarwal; Pauline Camacho
Journal:  Postgrad Med       Date:  2006 Jun-Jul       Impact factor: 3.840

4.  Pitfalls in the measurement of bone mineral density by dual energy x-ray absorptiometry.

Authors:  M D Antonacci; D S Hanson; M H Heggeness
Journal:  Spine (Phila Pa 1976)       Date:  1996-01-01       Impact factor: 3.468

5.  [Bone densitometry and ultrasound studies of the bone: methods, indications and efficacy].

Authors:  P H Kann
Journal:  Orthopade       Date:  2001-07       Impact factor: 1.087

Review 6.  Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).

Authors:  Nelson B Watts
Journal:  Osteoporos Int       Date:  2004-08-21       Impact factor: 4.507

Review 7.  [Bone densitometry in inflammatory rheumatic diseases : Characteristics of the measurement site and disease-specific factors].

Authors:  H Franck; J Braun; F Buttgereit; W Demary; G Hein; J Kekow; G Schett; P M Kern
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

8.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

Review 9.  Dual energy x-ray absorptiometry and its clinical applications.

Authors:  Glen M Blake; Ignac Fogelman
Journal:  Semin Musculoskelet Radiol       Date:  2002-09       Impact factor: 1.777

Review 10.  Vertebral Fracture Assessment by dual-energy X-ray absorptiometry: insurance coverage issues in the United States. A White Paper of the International Society for Clinical Densitometry.

Authors:  Andrew J Laster; E Michael Lewiecki
Journal:  J Clin Densitom       Date:  2007-06-28       Impact factor: 2.617

View more
  1 in total

1.  [62/f-unsteady walking and falls in the home environment : Preparation for the medical specialist examination-case 21].

Authors:  D Sauer
Journal:  Orthopade       Date:  2021-04       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.